134 related articles for article (PubMed ID: 11044643)
1. Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer.
Urgell E; Puig P; Boadas J; Capellà G; Queraltó JM; Boluda R; Antonijuan A; Farré A; Lluís F; González-Sastre F; Mora J
Eur J Cancer; 2000 Oct; 36(16):2069-75. PubMed ID: 11044643
[TBL] [Abstract][Full Text] [Related]
2. [Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].
Dai MH; Zhao YP; Cai LX; Zhu Y
Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):332-5. PubMed ID: 12892584
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.
Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A
Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770
[TBL] [Abstract][Full Text] [Related]
4. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.
Theodor L; Melzer E; Sologov M; Idelman G; Friedman E; Bar-Meir S
Dig Dis Sci; 1999 Oct; 44(10):2014-9. PubMed ID: 10548352
[TBL] [Abstract][Full Text] [Related]
5. Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer: correlation with clinical features and carbohydrate antigen 19-9.
Däbritz J; Preston R; Hänfler J; Oettle H
Pancreas; 2009 Jul; 38(5):534-41. PubMed ID: 19295453
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
7. [Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma].
Zhang Y; Ji SR; Feng DX; Ji J; Han TQ
Ai Zheng; 2003 Mar; 22(3):295-7. PubMed ID: 12654190
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.
Maire F; Micard S; Hammel P; Voitot H; Lévy P; Cugnenc PH; Ruszniewski P; Puig PL
Br J Cancer; 2002 Aug; 87(5):551-4. PubMed ID: 12189555
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.
Villanueva A; Reyes G; Cuatrecasas M; Martínez A; Erill N; Lerma E; Farré A; Lluís F; Capellá G
Gastroenterology; 1996 May; 110(5):1587-94. PubMed ID: 8613066
[TBL] [Abstract][Full Text] [Related]
10. Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.
Parker LA; Porta M; Lumbreras B; López T; Guarner L; Hernández-Aguado I; Carrato A; Corominas JM; Rifà J; Fernandez E; Alguacil J; Malats N; Real FX
Eur J Epidemiol; 2011 Mar; 26(3):229-36. PubMed ID: 21298467
[TBL] [Abstract][Full Text] [Related]
11. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of K-ras mutations in serum of pancreatic cancer patients.
Theodor L; Melzer E; Sologov M; Bar-Meir S
Ann N Y Acad Sci; 2000 Apr; 906():19-24. PubMed ID: 10818590
[No Abstract] [Full Text] [Related]
13. K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis.
Wenger FA; Zieren J; Peter FJ; Jacobi CA; Müller JM
Langenbecks Arch Surg; 1999 Apr; 384(2):181-6. PubMed ID: 10328172
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer.
Salek C; Benesova L; Zavoral M; Nosek V; Kasperova L; Ryska M; Strnad R; Traboulsi E; Minarik M
World J Gastroenterol; 2007 Jul; 13(27):3714-20. PubMed ID: 17659731
[TBL] [Abstract][Full Text] [Related]
15. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
[TBL] [Abstract][Full Text] [Related]
17. K-ras gene mutations in the diagnosis of fine-needle aspirates of pancreatic masses: prospective study using two techniques with different detection limits.
Mora J; Puig P; Boadas J; Urgell E; Montserrat E; Lerma E; González-Sastre F; Lluís F; Farré A; Capellá G
Clin Chem; 1998 Nov; 44(11):2243-8. PubMed ID: 9799749
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of detection of pancreatic carcinoma by combined plasma K-ras mutations and serum CA19-9 analysis.
Dianxu F; Shengdao Z; Tianquan H; Yu J; Ruoqing L; Zurong Y; Xuezhi W
Pancreas; 2002 Nov; 25(4):336-41. PubMed ID: 12409826
[TBL] [Abstract][Full Text] [Related]
19. K-ras gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses.
Zheng M; Liu LX; Zhu AL; Qi SY; Jiang HC; Xiao ZY
World J Gastroenterol; 2003 Jan; 9(1):188-91. PubMed ID: 12508380
[TBL] [Abstract][Full Text] [Related]
20. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer.
Berthélemy P; Bouisson M; Escourrou J; Vaysse N; Rumeau JL; Pradayrol L
Ann Intern Med; 1995 Aug; 123(3):188-91. PubMed ID: 7598300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
